Randy D. Milby, Chief Executive Officer. Mr. Milby is an established leader with executive accomplishments in the global pharmaceutical, medical device, agricultural and bio-polymer industries. He has led commercial operations for several businesses including profit/loss responsibility, product development functions, international product launches, domestic and international negotiations to develop partnerships, and financial management. Mr. Milby began his career in the pharmaceutical industry assessing markets and shepherding compounds from research through launch. Then he transitioned from launching products to launching businesses. He utilizes market research to gain an understanding of new markets and provides necessary leadership to highly productive teams working on complex projects. During his career he has worked at Bristol-Myers Squibb, DuPont Merck Pharmaceuticals, Goldman Sachs and DuPont. Mr. Milby received his B.S from the Kansas School of Pharmacy and earned his Master of Business Administration with an emphasis in marketing and finance from Washington University in St. Louis.
Steven W. Lefkowitz, Interim Chief Financial Officer. Mr. Lefkowitz has been the President and Founder of Wade Capital Corporation which focuses on small to middle market firms as it relates to setting strategy, developing business plans, raising capital, and identifying and executing business development transactions. Mr. Lefkowitz currently holds Board positions in both publicly traded and privately held companies. Mr. Lefkowitz holds an M.B.A. in finance from Columbia University Graduate School of Business.
Antony E. Pfaffle, M.D., Acting Chief Scientific Officer. Dr. Pfaffle is the Advisory Chief Medical Officer at ParagonRx, an Inventiv Health Company. He has been the Director of Healthcare Research at Bearing Circle Capital, L.P., an investment fund, since May 2007. He was a Managing Director at Paramount BioCapital, Inc. and Senior Vice-President of Business Development at Paramount BioSciences, LLC from December 2005 to May 2007. Dr. Pfaffle was a Principal and Founder of Black Diamond Research, an investment research company, from July 2001 to December 2005. Dr. Pfaffle is an internist who practiced nephrology at New York Hospital, Lenox Hill and Memorial Sloan-Kettering. Dr. Pfaffle received his M.D. degree from New York Medical College in 1989.
William J Vanjonack, Ph.D., Vice President - Manufacturing & Quality Operations. Dr. Vanjonack is a Manufacturing and Quality professional with in depth domestic and international pharmaceutical and medical devices experience. He is the Managing Director at Pioneer CR, LLC providing production, quality, technical support, supply chain and strategic sourcing to the industry. He has held positions of increasing responsibility at Bristol-Myers Squibb/DuPont Merck/DuPont Pharmaceuticals, and has served as VP of Quality for Damon Biotech and Osteotech. Dr. Vanjonack earned his Ph.D. from the University of Missouri-Columbia and was a NIH Research Fellow at MGH and Harvard Medical School. He is currently a Member of the University of Missouri Research & Development Advisory Board.